165 Results

People

  1. Old
    Old
  2. Ritter
    Ritter
  3. Houghton
    Houghton
  4. Gnjatic
    Gnjatic
  5. Allison
    Allison
  6. Pamer
    Pamer
  7. Fong
    Fong
  8. Dupont
    Dupont
  9. Scheinberg
    Scheinberg
  10. Wolchok
    Wolchok

Groups

  1. Department of Medicine (56)
  2. Sloan Kettering Institute Faculty (56)
  3. GSK Faculty (53)
  4. Immunology Program Faculty (39)
  5. Sloan Kettering Institute Postdocs (37)
  6. Hematologic Malignancies, Division of (29)
  7. Center for Hematologic Malignancies (27)
  8. Solid Tumor Oncology Division (24)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)
  10. Melanoma and Immunotherapeutics Service (19)
  1. "cd4-positive t-lymphocytes"
Formats
  1. Journal Article (164)
  2. Guidelines (1)
Groups
  1. Department of Medicine (56)
  2. Sloan Kettering Institute Faculty (56)
  3. GSK Faculty (53)
  4. Immunology Program Faculty (39)
  5. Sloan Kettering Institute Postdocs (37)
  6. Hematologic Malignancies, Division of (29)

More Groups

People
  1. Lloyd Old (28)
  2. Gerd Ritter (18)
  3. Alan Houghton (16)
  4. Jedd Wolchok (15)
  5. Sacha Gnjatic (14)
  6. James Allison (12)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (4)
  5. 2017 (1)
  6. 2014 (1)

More Years

Publications
  1. Journal of Immunology (23)
  2. Journal of Experimental Medicine (12)
  3. Blood (11)
  4. Clinical Cancer Research (11)
  5. Proceedings of the National Academy of Sciences of the United States of America (8)
  6. Journal of Clinical Investigation (7)

More Publications

Publishers
  1. The American Association of Immunologists, Inc (23)
  2. American Association for Cancer Research (15)
  3. Nature Publishing Group (12)
  4. Rockefeller University Press (12)
  5. American Society of Hematology (11)
  6. Elsevier Inc. (10)

More Publishers

Results (165)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates
    Journal Article

    Di Mascio, M.; Paik, C. H.; Carrasquillo, J. A.; Maeng, J. S.; Jang, B. S.; In, S. S.; Srinivasula, S.; Byrum, R.; Neria, A.; Kopp, W.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cells
    Journal Article

    Dao, T.; Korontsvit, T.; Zakhaleva, V.; Haro, K.; Packin, J.; Scheinberg, D. A.
    PLoS ONE (2009)

    Fulltext@MSK | Save
  • Anti-CTLA-4 therapy results in higher CD4(+)ICOS(hi) T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues
    Journal Article

    Chen, H.; Liakou, C. I.; Kamat, A.; Pettaway, C.; Ward, J. F.; Tang, D. N.; Sun, J.; Jungbluth, A. A.; Troncoso, P.; Logothetis, C.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire
    Journal Article

    Bioley, G.; Dousset, C.; Yeh, A.; Dupont, B.; Bhardwaj, N.; Mears, G.; Old, L. J.; Ayyoub, M.; Valmori, D.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
    Journal Article

    Quezada, S. A.; Peggs, K. S.; Simpson, T. R.; Shen, Y.; Littman, D. R.; Allison, J. P.
    Journal of Experimental Medicine (2008)

    Fulltext@MSK | Save
  • Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
    Journal Article

    Tsuji, K.; Hamada, T.; Uenaka, A.; Wada, H.; Sato, E.; Isobe, M.; Asagoe, K.; Yamasaki, O.; Shiku, H.; Ritter, G.; more...
    Cancer Immunology, Immunotherapy (2008)

    Fulltext@MSK | Save
  • Phase II study of extended-dose temozolomide in patients with melanoma
    Journal Article

    Rietschel, P.; Wolchok, J. D.; Krown, S.; Gerst, S.; Jungbluth, A. A.; Busam, K.; Smith, K.; Orlow, I.; Panageas, K.; Chapman, P. B.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease
    Journal Article

    Maslak, P. G.; Dao, T.; Gomez, M.; Chanel, S.; Packin, J.; Korontsvit, T.; Zakhaleva, V.; Pinilla-Ibarz, J.; Berman, E.; Scheinberg, D. A.
    Leukemia (2008)

    Fulltext@MSK | Save
  • CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4 + T cells in a dose-dependent fashion
    Journal Article

    Kavanagh, B.; O'Brien, S.; Lee, D.; Hou, Y.; Weinberg, V.; Rini, B.; Allison, J. P.; Small, E. J.; Fong, L.
    Blood (2008)

    Fulltext@MSK | Save
  • Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1
    Journal Article

    Hunder, N. N.; Wallen, H.; Cao, J.; Hendricks, D. W.; Reilly, J. Z.; Rodmyre, R.; Jungbluth, A.; Gnjatic, S.; Thompson, J. A.; Yee, C.
    New England Journal of Medicine (2008)

    Fulltext@MSK | Save